| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 9 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 9 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 9 |
| 3 | NILOTINIB | 7 |
| 4 | CLOZAPINE | 6 |
| 5 | RITUXIMAB | 6 |
| 6 | DOXORUBICIN | 5 |
| 7 | HYDROXYUREA | 5 |
| 8 | FLUDARABINE PHOSPHATE | 4 |
| 9 | FUROSEMIDE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MIGLUSTAT | 3 | 0.0026 |
| 1 | RITUXIMAB AND HYALURONIDASE | 1 | 0.0022 |
| 2 | TEPLIZUMAB-MZWV | 1 | 0.0014 |
| 3 | ARSENIC TRIOXIDE | 2 | 0.0009 |
| 4 | TAZAROTENE | 1 | 0.0008 |
| 5 | IMIGLUCERASE | 3 | 0.0006 |
| 6 | ASCIMINIB | 2 | 0.0006 |
| 7 | ROPEGINTERFERON ALFA-2B | 1 | 0.0005 |
| 8 | FLUDROCORTISONE ACETATE | 1 | 0.0004 |
| 9 | PONATINIB HYDROCHLORIDE | 2 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 9 |
| 1 | Kinase Inhibitor [EPC] | 9 |
| 2 | Atypical Antipsychotic [EPC] | 8 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 8 |
| 4 | Corticosteroid [EPC] | 7 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 6 |
| 6 | Antimetabolite [EPC] | 5 |
| 7 | Loop Diuretic [EPC] | 4 |
| 8 | Mood Stabilizer [EPC] | 4 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Enzyme Stabilizer [EPC] | 3 | 0.0026 |
| 1 | CD3-directed Antibody [EPC] | 1 | 0.0014 |
| 2 | Glucosylceramide Synthase Inhibitor [EPC] | 3 | 0.0011 |
| 3 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 4 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 5 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 3 | 0.0004 |
| 6 | Thrombopoietin Receptor Agonist [EPC] | 3 | 0.0002 |
| 7 | Cannabinoid [EPC] | 1 | 0.0001 |
| 8 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 9 | Vitamin K [EPC] | 1 | 0.0001 |